What is the cost of pelvic inflammatory disease and how much could be prevented by screening for Chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial

Sexually Transmitted Infections

Volumn 87, Issue 4, 2011, Pages 312-317

  Aghaizu, Adamma ^a   Adams, Elisabeth J ^b   Turner, Katy ^c   Kerry, Sally ^a   Hay, Phillip ^d   Simms, Ian ^e   Oakeshott, Pippa ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Health Economics Department   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST BENEFIT ANALYSIS; ETHNIC GROUP; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING; SEXUALITY; UNITED KINGDOM;

ADOLESCENT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COST OF ILLNESS; COSTS AND COST ANALYSIS; FEMALE; HUMANS; INCIDENCE; LONDON; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE; PELVIC INFLAMMATORY DISEASE; PREVALENCE; QUALITY OF LIFE; YOUNG ADULT;

EID: 79956286964     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.2010.048694     Document Type: Article

References (28)

1. Kalwij S, Macintosh M, Baraitser P. Screening and treatment of Chlamydia trachomatis infections. BMJ 2010;340:C1915.
2. House of Commons Committee of Public Accounts. Young People's Sexual Health: The National Chlamydia Screening Programme. London: House of Commons Committee of Public Accounts, 2010.
3. National Audit Office. Young People's Sexual Health: The National Chlamydia Screening Programme. London: National Audit Office, 2010.
4. Low N, Bender N, Nartey L, et al. Effectiveness of chlamydia screening: systematic review. Int J Epidemiol 2009;38:435-48.
5. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010;340:c1642.
6. Adams EJ, Turner KME, Edmunds WJ. The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect 2007;83:267-74. (Pubitemid 47242502)
7. Westrom L. Decrease in incidence of women treated in hospital for acute salpingitis in Sweden. Genitourin Med 1988;64:59-63. (Pubitemid 18082123)
8. Deogan CL, Bocangel MKH, Wamala SP, et al. A cost-effectiveness analysis of the Chlamydia Monday - a community-based intervention to decrease the prevalence of chlamydia in Sweden. Scand J Public Health 2010;38:141-50.
9. Low N, McCarthy A, Macleod J, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess 2007;11:1.
10. Roberts TE, Robinson S, Barton P, et al. Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling. Sex Transm Infect 2006;82:193-200. (Pubitemid 43901584)
11. Oakeshott P, Kerry S, Atherton H, et al. Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. Trials 2008;9:73.
12. Hager WD, Eschenbach DA, Spence MR, et al. Criteria for Diagnosis and Grading of Salpingitis. Obstet Gynecol 1983;61:113-14. (Pubitemid 13212386)
13. Centers for Disease Control. Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 2006;55:56-7.
14. Curtis L. Unit Costs of Health and Social Care. Personal Services Research Unit. Canterbury: Univesity of Kent, 2009.
15. Pathway Analytics. Phase 1: Methodology of the Proposed Integrated Sexual Health Pricing and Currencies for London. London: Pathway Analytics, 2009. http://www.londonsexualhealth.org/tariffs.html (accessed 21 Mar 2011).
16. National Health Service. The September 2008 Electronic Drug Tariif. National Health Service, 2010. http://www.ppa.org.uk/ppa/edt-intro.htm (accessed 22 Mar 2011).
17. National Chlamydia Screening Programme. Guidance for the commissioners on the cost of providing chlamydia screening in primary care and the community: a review of costs in practice across England in 2009. National Chlamydia Screening Programme, UK, 2009.
18. Department of Health. Payment by Results: Guidance and Tariff for 2008e09. Department of Health, 2010. http://www.dh.gov.uk/en/ Managingyourorganisation/NHSFinancialReforms/DH-081238 (accessed 21 Mar 2011).
19. Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001;358:1835-42. (Pubitemid 34008648)
20. Fenton KA, Korovessis C, Johnson AM, et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001;358:1851-4. (Pubitemid 34008651)
21. Health Protecion Agency. Major Step Forward in Screening, 2010.
22. Anon. EuroQolda new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208.
23. Simms I, Rogers P, Charlett A. The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales. Int J STD & AIDS 1999;10:448-51. (Pubitemid 29312829)
24. French C, Hughes G, Yung M, et al. Can trends in Pelvic Inflammatory Disease Diagnoses in General Practice be Used to Evaluate Chlamydia Screening Programmes? ISSTDR, 2009. Ref Type: Abstract.
25. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-6. (Pubitemid 26152715)
26. Yeh JM, Hook EW 3rd, Goldie SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis 2003;30:369-78. (Pubitemid 36605484)
27. Smith KJ, Tsevat J, Ness RB, et al. Quality of life utilities for pelvic inflammatory disease health states. Sex Transm Dis 2008;35:307-11. (Pubitemid 351619537)
28. Ross J and the Clinical Effectiveness Group for BASHH. United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease. London: BASHH, 2005.